Showing results (1-10 of 107) with videos related to
Sort By:
Pageof 11
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 5, 2005
The effects of ximelagatran and warfarin on the prophylaxis of a caval vein thrombosis and bleeding in the anaesthetized ratStefan Carlsson, Margareta ElgThrombosis Research|November 15, 2002
Effects of ximelagatran, the oral form of melagatran, in the treatment of caval vein thrombosis in conscious ratsStefan Carlsson, Margareta Elg, Christer MattssonBiopharmaceutics & Drug Disposition|September 16, 2003
Three vehicle formulations for melagatran, a direct thrombin inhibitor, evaluated in a vena cava thrombosis model in the ratMargareta Elg, Inger Börjesson, Stefan CarlssonScandinavian Journal of Urology and Nephrology|April 13, 2006
Postoperative urinary continence after robot-assisted laparoscopic radical prostatectomyStefan Carlsson, Andreas Nilsson, Peter N WiklundScandinavian Journal of Urology|July 15, 2020
The value of a first MRI and targeted biopsies after several years of active surveillance for low-risk prostate cancer - results from the SAMS trialStefan Carlsson, Ola Bratt, Dushanka Kristiansson, et al.European Journal of Radiology|February 2, 2015
Synchronous rectal and prostate cancer--the impact of MRI on incidence and imaging findingsMargrét Sturludóttir, Anna Martling, Stefan Carlsson, et al.Scandinavian Journal of Urology and Nephrology|June 1, 2012
Current routines for transrectal ultrasound-guided prostate biopsy: a web-based survey by the Swedish Urology NetworkStefan Carlsson, Ola Bratt, Pär Stattin, et al.Antimicrobial Agents and Chemotherapy|May 27, 2005
Intravesical nitric oxide delivery for prevention of catheter-associated urinary tract infectionsStefan Carlsson, Eddie Weitzberg, Peter Wiklund, et al.Scandinavian Journal of Urology and Nephrology|November 30, 2006
Karolinska prostatectomy: a robot-assisted laparoscopic radical prostatectomy techniqueAndreas E Nilsson, Stefan Carlsson, Brett A Laven, et al.Scandinavian Journal of Urology|April 17, 2019
Triple treatment of high-risk prostate cancer. A matched cohort study with up to 19 years follow-up comparing survival outcomes after triple treatment and treatment with hormones and radiotherapyOlof Gunnarsson, Sonny Schelin, Lars Brudin, et al.Pageof 11